TY - JOUR
T1 - Coffee, green tea and liver cancer risk
T2 - An evaluation based on a systematic review of epidemiologic evidence among the Japanese population
AU - Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan
AU - Tanaka, Keitaro
AU - Tamakoshi, Akiko
AU - Sugawara, Yumi
AU - Mizoue, Tetsuya
AU - Inoue, Manami
AU - Sawada, Norie
AU - Matsuo, Keitaro
AU - Ito, Hidemi
AU - Naito, Mariko
AU - Nagata, Chisato
AU - Kitamura, Yuri
AU - Sadakane, Atsuko
AU - Tsugane, Shoichiro
AU - Shimazu, Taichi
N1 - Funding Information:
This study was supported by the National Cancer Center Research and Development Fund (30-A-15, 27-A-4, 24-A-3) and the Health and Labour Sciences Research Grants for the Third Term Comprehensive Control Research for Cancer (H21-3jigan-ippan-003, H18-3jigan-ippan-001, H16-3jigan-010).
Publisher Copyright:
© 2019 The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
PY - 2019/11/26
Y1 - 2019/11/26
N2 - Background: Coffee and green tea, two popular drinks in the Japanese, have recently drawn much attention as potential protective factors against the occurrence of liver cancer. Methods: We systematically reviewed epidemiologic studies on coffee, green tea and liver cancer among Japanese populations. Original data were obtained by searching the MEDLINE (PubMed) and Ichushi databases, complemented with manual searches. The evaluation was performed in terms of the magnitude of association in each study and the strength of evidence ('convincing', 'probable', 'possible', or 'insufficient'), together with biological plausibility. Results: We identified four cohort and four case-control studies on coffee and liver cancer and six cohort and one case-control studies on green tea and liver cancer. All cohort and case-control studies on coffee reported a weak to strong inverse association, with a summary relative risk (RR) for one cup increase being 0.72 (95% confidence interval [CI] 0.66-0.79). Conversely, all studies but two cohort studies on green tea reported no association, with a corresponding summary RR of 0.99 (95% CI 0.97-1.01, P = 0.37). Conclusion: Coffee drinking 'probably' decreases the risk of primary liver cancer among the Japanese population whereas the evidence on an association between green tea and liver cancer is 'insufficient' in this population.
AB - Background: Coffee and green tea, two popular drinks in the Japanese, have recently drawn much attention as potential protective factors against the occurrence of liver cancer. Methods: We systematically reviewed epidemiologic studies on coffee, green tea and liver cancer among Japanese populations. Original data were obtained by searching the MEDLINE (PubMed) and Ichushi databases, complemented with manual searches. The evaluation was performed in terms of the magnitude of association in each study and the strength of evidence ('convincing', 'probable', 'possible', or 'insufficient'), together with biological plausibility. Results: We identified four cohort and four case-control studies on coffee and liver cancer and six cohort and one case-control studies on green tea and liver cancer. All cohort and case-control studies on coffee reported a weak to strong inverse association, with a summary relative risk (RR) for one cup increase being 0.72 (95% confidence interval [CI] 0.66-0.79). Conversely, all studies but two cohort studies on green tea reported no association, with a corresponding summary RR of 0.99 (95% CI 0.97-1.01, P = 0.37). Conclusion: Coffee drinking 'probably' decreases the risk of primary liver cancer among the Japanese population whereas the evidence on an association between green tea and liver cancer is 'insufficient' in this population.
KW - coffee
KW - green tea
KW - Japanese
KW - liver cancer
KW - meta-analysis
KW - systematic review
UR - http://www.scopus.com/inward/record.url?scp=85076170567&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076170567&partnerID=8YFLogxK
U2 - 10.1093/jjco/hyz097
DO - 10.1093/jjco/hyz097
M3 - Article
C2 - 31790152
AN - SCOPUS:85076170567
SN - 0368-2811
VL - 49
SP - 972
EP - 984
JO - Japanese Journal of Clinical Oncology
JF - Japanese Journal of Clinical Oncology
IS - 10
ER -